These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247 [TBL] [Abstract][Full Text] [Related]
5. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078 [TBL] [Abstract][Full Text] [Related]
6. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas. Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478 [TBL] [Abstract][Full Text] [Related]
7. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828 [TBL] [Abstract][Full Text] [Related]
8. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Kirla RM; Haapasalo HK; Kalimo H; Salminen EK Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606 [TBL] [Abstract][Full Text] [Related]
9. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma. Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and alterations in telomere length in human brain tumors. Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755 [TBL] [Abstract][Full Text] [Related]
11. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors. Erdamar S; Bagci P; Oz B; Dirican A J BUON; 2006; 11(2):213-6. PubMed ID: 17318973 [TBL] [Abstract][Full Text] [Related]
12. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
13. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas. Eneström S; Vavruch L; Frånlund B; Nordenskjöld B Neurochirurgie; 1998 Mar; 44(1):25-30. PubMed ID: 9757314 [TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres]. Korshunov AG; Sycheva RV Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938 [TBL] [Abstract][Full Text] [Related]
16. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366 [TBL] [Abstract][Full Text] [Related]
17. AgNOR- and PCNA-studies in astrocytomas of the optic nerve. Patt S; Giraldo M; Martin H Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678 [TBL] [Abstract][Full Text] [Related]
18. Tenascin expression in astrocytomas correlates with angiogenesis. Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours. Hara A; Saegusa M; Ichinoe M; Okayasu I J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430 [TBL] [Abstract][Full Text] [Related]
20. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas. Gunal A; Onguru O; Safali M; Beyzadeoglu M Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]